Cytogen, Inc. (KOSDAQ:217330)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,605.00
+830.00 (29.91%)
At close: Oct 10, 2025

Cytogen Revenue

Cytogen had revenue of 6.29B KRW in the quarter ending June 30, 2025, with 426.60% growth. This brings the company's revenue in the last twelve months to 20.80B, up 485.41% year-over-year. In the year 2024, Cytogen had annual revenue of 10.91B with 242.63% growth.

Revenue (ttm)
20.80B
Revenue Growth
+485.41%
P/S Ratio
4.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
83.17B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202410.91B7.73B242.63%
Dec 31, 20233.18B2.42B318.57%
Dec 31, 2022760.78M412.93M118.71%
Dec 31, 2021347.85M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition